Clinical Trial Update: A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ASP3550 with Goserelin in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ASP3550
• Goserelin (Goserelin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED